Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 1 day agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 3 hours agoThe studies also achieved a key secondary endpoint of endoscopic improvement. Skyrizi is already...
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 hours agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most recent 13F filing ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Michael S. Ryan Inc.
ETF DAILY NEWS· 8 hours agoMichael S. Ryan Inc. lowered its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor ...
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Short Interest Up 11.1% in May
ETF DAILY NEWS· 15 hours agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling ...
First Financial Bank Trust Division Has $345,000 Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 8 hours agoFirst Financial Bank Trust Division lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.2% during the first quarter, according to the company in its most recent Form 13F filing ...
Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June
InvestorPlace via Yahoo Finance· 6 days agoBuilding a solid retirement portfolio to carry you through your golden years requires just a few key...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 18 hours agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...